Asahi Kasei

Asahi Kasei to Exit MMA and PMMA Businesses

Asahi Kasei will end the production of methyl methacrylate (MMA) monomer and other chemicals and focus on its Energy & Infrastructure division.

Asahi Kasei: Ken Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector

Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.

Asahi Kasei Launches Life Science Division to Boost Bioprocess Innovation

To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.

Asahi Kasei to Build a Battery Separator Plant in Canada

Asahi Kasei announced that it will construct an integrated plant in Ontario, Canada for the base film manufacturing and coating of Hipore wet-process lithium-ion battery (LIB) separator. Asahi Kasei and Honda Motor Co., Ltd. (Honda) have reached a basic agreement about the plant and are currently exploring the possibility of a joint investment.

Asahi Kasei Invests in Canadian Anion Exchange Membranes Manufacturer

Japanese manufacturer Asahi Kasei invests in Canadian startup Ionomr Innovations, known for its high-performance anion exchange membrane (AEM). The membrane has applications in cost-efficient and scalable green hydrogen production.

Asahi Kasei to Increase Lithium-Ion Battery Separator Coating Capacity

Asahi Kasei will invest in new coating equipment for Hipore lithium-ion battery separators in its US, Japan, and South Korea facilities, starting in the first half of fiscal year 2026. The increased capacity will provide coated separators for batteries powering up to 1.7 million electric vehicles.

Asahi Kasei Starts Work on Hydrogen Chain

Japan-based multinational chemical producer Asahi Kasei has begun construction of an alkaline water electrolysis pilot test plant for hydrogen production in Kawasaki, Japan.

Asahi Kasei Medical Buys Bionova Scientific

Asahi Kasei Medical, through a US subsidiary, has agreed to buy biologics CDMO Bionova Scientific for an undisclosed sum. Located in Fremont, California, Bionova provides process development services to biopharmaceutical companies, especially those developing next-generation antibody-based drugs.

CO2-Neutral Chemical Industry

The European Chemical Industry has set out on an ambitious path to become carbon neutral. Germany, as one of the major chemical manufacturing nations, has committed to achieve this goal by 2050.

Developing Innovative Ideas, Creating New Markets

As Managing Director of Asahi Kasei Europe, Hideki Tsutsumi has implemented the Japanese chemical company's growth strategy in Europe.

Expert Statement: Tatsuhiko Tokunaga, Asahi Kasei

The European Chemical Industry has set out on an ambitious path to become carbon neutral.

Creating for Tomorrow - a New Concept Car

Marine Litter, Tighter Regulations, Progressive Digitalization

Material Solutions for the Automotive Industry

Completion of Neolyse's Membrane Electrolysis Plant in Germany

Asahi Develops CO2 Route to Diphenyl Carbonate

Asahi Kasei and Bluestar Studying mPPE

Asahi Kasei: Lower Power Consumption Technology for the Chlor-Alkali Industry

Asahi Kasei Seeks European Expansion

Mitsubishi and Asahi Kasei in Cracker JV

Chlor-Alkali Strives to Stay Competitive

Japan's Asahi Kasei to buy U.S. Zoll for $2.2 Billion

Some Key Facts On The Actelion Vs. Asahi Case

Pressure On Actelion Rises After Asahi Case Decision

Asahi Awarded Up To $547 Million In Actelion Case

SABIC In Chemicals JV With Japan's Asahi, Mitsubishi

Asahi Kasei to Team Up with Nissan Motor, Omron to Develop Power Storage System

Mitsubishi Chemicals, Asahi Kasei JV Starts April 2011